A first-in-human study of CD123 NK cell engager SAR443579 in relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia, or high-risk myelodysplasia.

被引：0
|
作者：
Stein, Anthony Selwyn
Jongen-Lavrencic, Mojca
Garciaz, Sylvain
Huls, Gerwin A.
Maiti, Abhishek
Boissel, Nicolas
De Botton, Stephane
Fleming, Shaun
Zwaan, C. Michel
de Leeuw, David C.
Desai, Pinkal
Arellano, Martha Lucia
Avigan, David
Langemeijer, Saskia
Jensen, Kyle A.
Wagenaar, Timothy
Mi, Gu
Abbadessa, Giovanni
Bajel, Ashish
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] Erasmus MC, Rotterdam, Netherlands
[3] Aix Marseille Univ, Inst Paoli Calmettes, Marseille, France
[4] Univ Med Ctr Groningen, Groningen, Netherlands
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[6] Hop St Louis, Paris, France
[7] Inst Gustave Roussy, Paris, France
[8] Alfred Hlth, Melbourne, Australia
[9] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[10] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[11] Weill Cornell Med, New York, NY USA
[12] Emory Univ, Atlanta, GA USA
[13] Beth Israel Deaconess Med Ctr, Boston, MA USA
[14] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[15] Sanofi, Cambridge, MA USA
[16] Peter MacCallum Canc Ctr, Melbourne, Australia
[17] Royal Melbourne Hosp, Melbourne, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7005
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CD19-CAR-T Therapy Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Refractory/Relapsed and High Risk B-Cell Acute Lymphoblastic Leukemia
    Zhao, Yanli
    Zhang, Jianping
    Liu, Deyan
    Xiong, Min
    Wei, Zhijie
    Sun, Ruijuan
    Zhou, Jiarui
    Lu, Yue
    Cao, Xingyu
    Yang, Junfang
    Zhang, Xian
    Wang, Hui
    Liu, Hongxing
    Lu, Peihua
    Lu, Daopei
    BLOOD, 2018, 132
  • [42] Blinatumomab: A First-in-Class Bispecific T-Cell Engager for Precursor B-Cell Acute Lymphoblastic Leukemia
    Buie, Larry W.
    Pecoraro, Joshua J.
    Horvat, Troy Z.
    Daley, Ryan J.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (09) : 1057 - 1067
  • [43] Blinatumomab Combined with Venetoclax Increasing the Abundance of CD8 T Cell and NK Cell and Improve the Outcome in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients
    Hu, Lijuan
    Wang, Ya-Zhe
    Wang, Xiang
    Li, Zongru
    Zhao, Ting
    Duan, Wenbing
    Yu, Lu
    Jiang, Qian
    BLOOD, 2024, 144 : 2815 - 2816
  • [44] ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR REDIRECTED T CELLS FOR RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Ruella, M.
    Shestova, O.
    Kenderian, S.
    Barrett, D.
    Grupp, S.
    Scholler, J.
    Lacey, S.
    Kalos, M.
    June, C. H.
    Gill, S.
    CYTOTHERAPY, 2014, 16 (04) : S8 - S8
  • [45] Successful Treatment of High-Risk and Refractory Acute Myeloid Leukemia with haploidentical Stem Cell Transplantation Plus NK cell therapy
    Uharek, Lutz
    Friedrichs, Birte
    Nogai, Axel
    Gentilini, Chiara
    Basara, Nadezda
    Niederwieser, Dietger
    Thiel, Eckhard
    BLOOD, 2010, 116 (21) : 982 - 982
  • [46] FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B-Cell Acute Lymphoblastic Leukemia
    Pulte, E. Dianne
    Vallejo, Jonathon
    Przepiorka, Donna
    Nie, Lei
    Farrell, Ann T.
    Goldberg, Kirsten B.
    McKee, Amy E.
    Pazdur, Richard
    ONCOLOGIST, 2018, 23 (11): : 1366 - 1371
  • [47] Clinical Insights on Brexucabtagene Autoleucel for the Treatment of Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
    Kopmar, Noam E.
    Cassaday, Ryan D.
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 1587 - 1596
  • [48] Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia
    Badar, Talha
    Szabo, Aniko
    Dinner, Shira
    Liedtke, Michaela
    Burkart, Madelyn
    Shallis, Rory M.
    Yurkiewicz, Ilana R.
    Kuo, Eric
    Khan, Muhammad Ali
    Balasubramanian, Suresh
    Yang, Jay
    Hefazi, Mehrdad
    Podoltsev, Nikolai
    Patel, Anand
    Curran, Emily
    Wang, Amy
    Arslan, Shukaib
    Aldoss, Ibrahim
    Siebenaller, Caitlin
    Mattison, Ryan J.
    Litzow, Mark R.
    Wadleigh, Martha
    Advani, Anjali S.
    Atallah, Ehab
    CANCER, 2021, 127 (07) : 1039 - 1048
  • [49] Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
    Enrico Maffini
    Francesco Saraceni
    Francesco Lanza
    Clinical Hematology International, 2019, 1 (2) : 85 - 93
  • [50] Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia
    Claviez, A
    Eckert, C
    Seegel, K
    Schrauder, A
    Schrappe, M
    Henze, G
    von Stackelberg, A
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (02): : 272 - 273
12345